Advertisement
News
Subscribe to MDT Magazine News

Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich's Genousâ„¢ Stent in Diabetic Patients

March 23, 2011 5:34 am | by Bio-Medicine.Org | Comments

HONG KONG, March 23, 2011 /- OrbusNeich today announced that 12-month outcomes data from a subset analysis of the global e-HEALING registry were published online ahead of print in the Journal of Interventional Cardiology and demonstrated the effectiveness and safety of the company's...

TOPICS:

Poll: Do You Use Twitter?

March 23, 2011 5:33 am | by Diagnostic Imaging | Comments

Twitter's popularity continues to grow, and hundreds of physicians are turning to the 140-character platform to connect and share information. Do you tweet?

TOPICS:

Are Your Managed Care Agreements Performing?

March 23, 2011 5:32 am | by Diagnostic Imaging | Comments

As providers continue to wrestle with both the planned and unknown annual reductions in reimbursement, it is critically important to understand the managed care component of your payer mix - and more importantly, to understand if each contract is delivering its intended benefit(s).

TOPICS:
Advertisement

PRA International Experts to Speak at Industry Events

March 23, 2011 5:32 am | by Bio-Medicine.Org | Comments

RALEIGH, N.C., March 23, 2011 /- PRA International, a leading Clinical Research Organization, announces that two of our experts will be speakers at the upcoming Partnerships in Clinical Trials and Late Phase Drug Development conferences. PRA will also be exhibiting at both conferences....

TOPICS:

Huifeng Bio-Pharmaceutical Technology Announces New Senior Vice President of Finance

March 23, 2011 4:33 am | by Bio-Medicine.Org | Comments

XI'AN, China, March 23, 2011 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB ) ("Huifeng" or "the Company"), specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives,...

TOPICS:

DATATRAK to Attend DIA's 23rd Annual EuroMeeting

March 23, 2011 4:32 am | by Bio-Medicine.Org | Comments

CLEVELAND, March 23, 2011 /- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its participation in the Drug Information Association's EuroMeeting. The 23rd Annual...

TOPICS:

NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002

March 23, 2011 4:32 am | by Bio-Medicine.Org | Comments

KALAMAZOO, Mich., March 23, 2011 /- NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.  Previously, NephRx reported that NX002 had demonstrated significant...

TOPICS:

New Nationwide Survey Identifies Need for Increased Dialogue Between Gastroesophageal Reflux Disease or Frequent Heartburn Sufferers and Health Care Providers

March 23, 2011 4:32 am | by Bio-Medicine.Org | Comments

BETHESDA, Md., March 23, 2011 /- According to findings from the new nationwide DISCUSS ( D efining and I dentifying Gap S in C omm U nication between GERD and/or Heartburn S ufferers and Physician S ) Survey, many people surveyed report that their gastroesophageal reflux disease (GERD)...

TOPICS:
Advertisement

Functional Technologies Strengthens Advisory Board with Addition of John Campbell

March 23, 2011 3:45 am | by The Associated Press | Comments

http://www.functionaltechcorp.com () —Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") announced today that it has appointed Mr. John Campbell to its Advisory Board.Possessing over 29 years of extensive experience in the investment industry, with significant expertise in...

Xenon Chief Scientific Officer, Dr. Michael Hayden Receives Prestigious Award for Leadership in Medicine

March 23, 2011 2:37 am | by Bio-Medicine.Org | Comments

VANCOUVER, British Columbia, March 23, 2011 /- Dr. Michael Hayden, a Xenon founder and Chief Scientific Officer, has received the Canada Gairdner Wightman Award for leadership in medical science in Canada. The Wightman Award is another major honour for Dr. Hayden, having previously been...

TOPICS:

Winner Medical Wins the Circular Economy Project Award

March 23, 2011 2:36 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, March 23, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ), ("Winner Medical"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, proudly announced today that...

TOPICS:

Kionix?s production speed advances fivefold with SPEA robotic test systems

March 22, 2011 8:38 pm | by I-Micronews | Comments

SPEA?s complete single-manufacturer MEMS test solution boosts Kionix?s throughput.

Making Cells on an Assembly Line

March 22, 2011 8:37 pm | by Massachusetts Institute of Technology | Comments

A chip-based method to churn out cell membranes could aid the development of novel proteins and synthetic cells.

S & P sees 'positive' outlook for Skilled Healthcare

March 22, 2011 2:45 pm | by The Associated Press | Comments

Standard & Poor's Ratings Services on Tuesday raised the outlook for nursing home operator Skilled Healthcare Group Inc. to "positive" from "stable" and affirmed its "B" corporate credit rating.S&P said the company's operating prospects are improving. Revised Medicare payment classifications...

Boston Scientific to Webcast Analyst Event

March 22, 2011 1:34 pm | by Boston Scientific | Comments

NATICK, Mass., March 22, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it will hold an analyst event on April 4, 2011 at the 60th Annual Scientific Session of the American College of Card

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading